As part of the Finding of Rare Disease Genes (FORGE) research project, Canadian researchers have developed an expertise in understanding the underlying biology of rare childhood disorders. The first public commentary of this nationwide study isavailable today in the American Journal of Human Genetics.
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington’s disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutic
Genome Canada today released a request for applications for membership in the Genomics Innovation Network (GIN) and core operations support funds. The network will create a mechanism for cross-country collaboration in providing access to the highest quality genomic technologies and advice to the research community.
Recent advances in genome sequencing technology havefacilitated rapid identification of genetic alterations in genes associated withAutism Spectrum Disorder (ASD). The universal challenge in the field ofgenetics has been to determine whether these mutations will result in autism.
PEDv, an extremely infectious coronavirus that infects the small intestine of a pig, causes severe diarrhea and dehydration leading to high piglet mortality. The United States PEDv epidemic has had substantial economic impact since its May, 2013 discovery. In a single year, PEDv has spread across 30 states, killing millions of pigs and resulting in an estimated loss of 10% of the U.S. pig population.
In the last few decades, acute lymphoblastic leukemia (ALL) has become a cancer success story with over 80 per cent survival among children. This has been achieved mostly through intensive chemotherapy, which that has improved outcomes for many, but unfortunately not for all. Still about 20 per cent of children with ALL will relapse, and survival among adults is just 40 per cent.
Their work days look very different — the aquaculture producer hauling in a full net, the farmer harvesting a bumper crop, the mining technician maximizing extraction, the biomedicine researcher developing a new therapy, the forester protecting trees from pests or the auto-parts maker using green materials.
From May 1 to June 30, 2014 Statistics Canada is inviting researchers to apply for access to blood, urine and DNA samples from the Biobank of the Canadian Health Measures Survey (CHMS for use in health studies. The biospecimens are available to any Canadian researcher that completes a review process and would benefit from a national population survey of about 5,600 participants per collection cycle.
Current advanced technologies for genetic analysis have created almost unimaginable amounts of data, measured in “petabytes” – a petabyte is a million billion bytes. Genomic researchers are keen to analyze these data and identify genetic clues that could point to new ways to prevent or cure cancer.